Gyne Flashcards

1
Q

List four non-molar gestational trophoblastic lesions

A

Placental site nodule

Epithelioid trophoblastic tumor

Placental site trophoblastic tumor

Gestational choriocarcinoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is the karyotype of a partial mole?

A

69XXY (or XYY, or XXX)- triploid

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is the pathogenesis of a partial mole?

A

Diandric triploidy: fertilization of a normal oocyte by two spermatozoa or single sperm that duplicates itself.

Two paternal and one maternal haploid set of DNA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is the karyotype and pathogenesis of a complete mole?

A

Diandric diploidy: two paternal sets of chromosomes, no maternal DNA.

= 46XX (usually) or XY

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is persistent gestational trophoblastic disease and what are the pathologic differential diagnoses?

A

Plateau or continued rise in beta-hcg after evacuation of a molar (or normal) pregnancy;

Pathologically corresponds to:

Persistent mole with no invasion
Invasive mole
choriocarcinoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is the risk of progression to choriocarcinoma in a Partial Mole and a Complete Mole?

A

Partial: <1%

CHM: 2 - 5%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is the pattern of p57 staining in partial and complete moles?

What is the internal positive control?

A

p57 staining is paternally imprinted (silenced) - expressed only in the maternal genome - in the villous STROMA and CYTOTROPHOBLAST.

Therefore:

p57 staining absent in Complete mole

p57 staining present in Partial mole

Positive INTERNAL CONTROL is the maternal tissue: decidua.
Intermediate trophoblast islands are fetal tissue but still retain some staining due to incomplete imprinting even in complete mole.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is the immunoprofile of Primary Extramammary Paget disease of the vulva? (at least two immunos and two special stains)

What would you use to differentiate it from Secondary extramammary paget disease?

A
Primary Extramammary Paget disease Positive:
CK7 & LMWCK (Cam 5.2); GATA3; GCDFP-15
CEA, mucicarmine, PAS-D, Alcian Blue
(CK20-, p63/p40-, CDX2-, SOX10-)
MUC1+ MUC5+

Secondary Paget, urothelial:
CK7+, CK20+, GATA3+, p63/p40+;
(GCDFP15-, CDX2-, SOX10-)

Secondary Paget, anorectal:
CK20+, CDX2+
(GATA3-, CK7-, SOX10-, GCDFP15-)
MUC2+

Quick Reference: 46.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

List 4 types of metaplasia that can be found in the cervix.

A

Squamous

Tubal

Tuboendometrioid (replacing cervical glands; endometriosis has the conspicuous stroma and hemosiderin)

Gastric/pyloric

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is the immunoprofile of endometriosis?

A

Positive:

ER/PR
Pax-2
Bcl-2
Stroma: CD10+, CD34- (opposite of cervical stromal cells)

Negative/patchy:

p16

Cervical stromal cells: CD10-, CD34+

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What immunos could you use to differentiate tunnel clusters from adenoma malignum?

A

Tunnel clusters: ER/PR +; p53 wild type; low ki67; p16 negative

Adenoma malignum: loss of ER/PR, p53 overexpression, high Ki67.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

List precursors of endometrial endometrioid carcinoma according to the latest WHO.

A

Endometrial hyperplasia without atypia

Atypical endometrial hyperplasia / endometrial intraepithelial neoplasia (AEH/EIN)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is the pathway mutated in EIN and list the key genes involved.

A

PI3K/AKT pathway

Genes:
PTEN (seen in hyperplasia)

MLH1
KRAS (key to EIN)

PIK3CA (40% of endometrioid carcinomas)

ARID1a is important for transition from atypical hyperplasia to EIN)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are the essential diagnostic criteria for nonatypical endometrial hyperplasia?

A
  • Increased endometrial gland–to–stroma ratio;
  • tubular, branching, and/or cystically dilated glands resembling proliferative endometrium;
  • uniform distribution of nuclear features across submitted tissue.

NB: criteria above are from WHO.
Nucci: characterized by increase in amount of glands at scanning magnification, in which glands occupy >50% of the area (gland to stroma ratio >1)
- stratification and polarity maintained

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are the essential and desirable diagnostic criteria for EIN?

A

Essential: morphologically defined endometrial changes with crowded glandular architecture and altered epithelial cytology, distinct from the surrounding endometrium and/or entrapped non-neoplastic glands.

Desirable: loss of immunoreactivity for PTEN, PAX2, or mismatch repair proteins.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

List the classification of intraepithelial lesions of the vulva.

What are their staining patterns for p16 and p53?

A
  1. Squamous intraepithelial lesions, HPV-associated, of the vulva (also known as usual VIN); low-grade VIN1 and high grade VIN2-3.
    p16 block positive, p53 wild-type
  2. Vulvar intraepithelial neoplasia, HPV-independent (also known as dVIN);
    p16 negative, p53 abnormal (null or diffuse)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

How do you differentiate LSIL from HSIL (semi-quantitatively) in the Vulva?

A

Atypia: involves lower 1/3 vs at least 1/2 to full-thickness;

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Define primary Paget of the vulva.

What is the immunoprofile of primary vulvar Paget disease?

A

Primary Paget: in situ adenocarcinoma of the vulvar skin, with or without underlying invasive adenocarcinoma. Secondary involvement of vulvar skin by carcinoma of rectal, bladder or cervical origin is designated “secondary Paget disease.”

POSITIVE:
ER/PR (HER2 less common)
CK7 (distinguishes from HPV-independent HSIL & melanoma)
EMA
CAM5.2 (LMWCK)
CEA
GATA3
!!! p16+/-
PAS (for mucin)
mucicarmine 
NEGATIVE:
melanoma markers
uroplakin-3
CDX2
CK20
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

How do you grade dVIN?

A

it is not graded!

20
Q

How many lymph nodes are normally examined in a vulvar specimen, and what are the designated “regional” nodes?

A

6

Regional nodes = inguinal and femoral

21
Q

How do you measure tumor thickness and depth of invasion in vulvar carcinoma?

A

Thickness: mm from the surface of the tumor or, if there is surface keratinization, from the bottom of the granular layer to the deepest point of tumor. Not used in staging, but used when the tumor is exophytic, surface ulcerated, or no adjacent epithelial-stromal junction, preventing measurement of depth of invasion.

Depth of invasion: in mm, from the epithelial-stromal junction of the adjacent, most superficial dermal papilla to the deepest point of invasion.
Alternative method: from BM of adjacent deepest dysplastic rete to the deepest point of invasion (tends to downstage).

22
Q

What are the strongest predictors of overall progression-free survival in vulvar carcinoma?

A

Tumor Stage

Lymph node status

23
Q

Which has better prognosis - HPV-associated or HPV-independent vulvar carcinoma?

A

HPV-associated.

24
Q

What are the 3 abnormal patterns of p53 expression (specifically from Vulvar CAP protocol)

A
  1. Block: uniformly strong, continuous basal cell nuclear overepression; cytoplasmic blush ok.
  2. Null: lack of nuclear or cytoplasmic expression;
  3. Abnormal cytoplasmic: diffusely to contiguously moderate to strongly positive while the nuclei are negative or variably stained.
25
Q

What are the main morphologic “types” of uVIN vs dVIN?

A

uVIN = Rare. younger. Warty or basaloid types. often multifocal. Less common (20%)

dVIN = Keratinizing
older; assoc. LSC; unifocal; more common (80%)

26
Q

What immunoprofile can you use to differentiate between endometrial endometrioid adenocarcinoma vs cervical endometrioid adenocarcinoma?

A

ENDOMETRIAL ENDOMETRIOID:

ER/PR : positive
p16 : negative
Vimentin : positive

CERVICAL ENDOMETRIOID:
ER/PR : negative
p16: positive
Vimentin : negative

Both are positive for PAX8
CEA can be positive in cervix adenoCa but it is really nonspecific.

27
Q

What is the immunoprofile of clear cell adenocarcinoma of the cervix / endometrium?

A

POSITIVE
Napsin
HNF-1B
PAX8

NEGATIVE
ER/PR
WT1
p53 wild type

28
Q

How do you differentiate between serous carcinoma of the ovary vs uterus?

A
Uterus: 
PAX8+
ER/PR 50%
p53 DIFFUSE OR NULL
p16 diffuse strong
very high ki67
****Wt1 negative
Ovary:
PAX8+
ER/PR 50%
P53 abnormal in high-grade
****Wt1 postiive
29
Q

What are the two major non-neoplastic causes of leukoplakia?

A

lichen sclerosus
squamous cell hyperplasia (a.k.a. lichen simplex chronicus)

Robbins p. 990

30
Q

what is the pathogenesis of lichen sclerosus?

A

autoimmune

Robbins p. 990

31
Q

list causes of dysfunctional uterine bleeding.

A
chronic endometritis
endometrial polyps
submucosal leiomyomas
endometrial neoplasms
hormonal disturbances.
32
Q

List 4 causes of chronic endometritis

A

IUD
Pelvic inflammatory disease
Tuberculosis
Retained products of conception

33
Q

List three “types” of endometriosis

A

Superficial peritoneal endometriosis
ovarian endometriosis
deep infiltrating endometriosis

Robbins p. 1004

34
Q

List 4 theories for the pathogenesis/distribution of endometriosis.

A

Regurgitation
Metaplasia
Metastasis
Stem cell

35
Q

List 2 ovarian carcinomas associated with endometriosis.

A

Clear Cell

Endometrioid

36
Q

List the squamous epithelial mimics, precusors and neoplasms of the uterine cervix according to the WHO.

A

mimics:

  • Squamous metaplasia
  • atrophy of the uterine cervix

Precursors and neoplasms:

  • condyloma acuminata of the uterine cervix
  • squamous intraepithelial neoplasia of the uterine cervix
  • squamous cell carcinoma, HPV-associated of the uterine cervix
  • squamous cell carcinoma, HPV-independent of the uterine cervix
  • squamous cell carcinoma, NOS (no access to HPV testing or p16)
37
Q

List benign glandular tumors of the uterine cervix according to the WHO.

A

Edocervical polyp
Mullerian papilloma of the uterine cervix
Nabothian cyst
Tunnel clusters
microglandular hyperplasia
Lobular endocervical glandular hyperplasia
Diffuse laminar endocervical hyperplasia
Mesonephric remnants and hyperplasia
Arias-Stella reaction of the uterine cervix
Endocervicosis of the uterine cervix
Tuboendometrioid metaplasia
Ectopic prostate

38
Q

List the classification of adenocarcinomas of the uterine cervix according to the WHO.

A

Adenocarcinoma in situ, HPV-associated, of the uterine cervix

Adenocarcinoma, HPV-associated of the uterine cervix

Adenocarcinoma in situ, HPV-independent, of the uterine cervix

Adenocarcinoma, HPV-independent, gastric type

Adenocarcinoma, HPV-independent, clear cell type

Adenocarcinoma, HPV-independent, mesonephric type

Other adenocarcinomas of the uterine cervix

39
Q

List the histologic types of HPV-associated adenocarcinoma of the uterine cervix

A

Usual type: <50% mucin (vast majority of cases are this type)
- has a villoglandular variant
(purely exophytic villoglandular conveys excellent prognosis)

Mucinous type: ~10% of endocervix adenocarcinomas; >50% of cells with intracytoplasmic mucin

subtypes:
- Mucinous NOS
- signet ring cell
- intestinal adenocarcinoma: goblet cells >50%
- stratified mucin-producing carcinoma (with a SMILE component).

40
Q

list causes (ddx) of atypical endometrial cells

NB: this explains why “Atypical endometrial cells, favour neoplasia, is not a category”

A

Endometrial polyps
IUD
Endometritis
Endometrial hyperplasia

= all benign conditions that mimic endometrial adenocarcinoma.
But the risk of carcinoma with the finding of atypical endometrial cells is high, so endometrial/endocervical sampling is recommended.

41
Q

What is the causative/etiological agent most commonly associated with small cell neuroendocrine carcinoma of the cervix?

A

HPV-18

42
Q

What is the pattern-based classification of HPV-associated adenocarcinoma of the uterine cervix?

A

Silva system: classifies adenoca of the cervix as A, B or C based on pattern of invasion.

A: non-destructive invasion (well-demarcated, no LVI) - conservative management

B: Early/focally destructive invasion (focally desmoplastic, can have LVI, no solid)

C: Diffusely destructive invasion (solid, desmoplastic, fills a 4x field, can have LVI);
- hysterectomy, lymphadenectomy and rads!

Significance: prognostic indicator of recurrence, lymph node metastases and survival.

43
Q

List reasons why a morphologically HPV-associated carcinoma of the uterine cervix may be p16 negative.

A

95% of cases show block-like/every cell staining.

rare cases:

  • methlyation inactivation of CDKN2A/p16
  • old or poorly-preserved tissue
  • if negative for mRNA chromogenic ISH, may be positive for an HPV subtype not covered by the assay.
44
Q

List important prognostic factors in HPV-associated adenocarcinoma of the uterine cervix.

A

WHO: Stage is the most important prognostic variable.

other factors:
Invasive pattern (pattern C, micropapillary is worse)
LVI
age of patient
KRAS and PIK3CA mutations associated with invasive patterns and prognosis.

45
Q

Which is worse prognosis, HPV-associated or independent adenocarcinoma of the cervix?

A

WHO: HPV-associated are associated with significantly better disease-free and disease-specific survival than their HPV-independent counterparts

46
Q

What is the molecular alteration is most often seen in mesonephric carcinoma of the uterine cervix?

What are mesonephric remnants?

A

KRAS

Wolffian duct that fails to regress

P16 negative, p53 wild type, HPV negative
Positive for PAX8, CD10, GATA3, TTF1, Calretinin

47
Q

List positive immunohistochemical and special stains in primary Paget’s disease of the vulva.

A

CK7+, EMA+, CAM5.2+
CEA+
GCDFP15+
GATA3+

NB: should be negative for uroplakin, CDX2, CK20. Also negative for melanoma markers.